South & Central America Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The South & Central America antimicrobial surgical suture market size is expected to reach US$ 31.52 million by 2031 from US$ 14.58 million in 2023. The market is estimated to record a CAGR of 10.2% from 2024 to 2031.

Executive Summary and South & Central America Antimicrobial Surgical Suture Market Analysis:

The South & Central America antimicrobial surgical suture market has been segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil accounted for the largest share of the South & Central America antimicrobial surgical suture market. The market growth in the country is defined by the aesthetic surgeries performed in large volumes, the availability of health insurance, and developments in the healthcare systems. Other countries in the region offer the best surgical treatments for various diseases at a lower cost compared to the developed countries. The growing medical tourism in these countries created a huge demand for antimicrobial surgical sutures, leading to the market growth in the region.

South & Central America Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the South & Central America antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the South & Central America antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the South & Central America antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the South & Central America antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

South & Central America Antimicrobial Surgical Suture Market Outlook

Sutures are frequently used to close post-operative wounds and to treat deep wounds caused during road and occupational accidents, orthopedic injuries, and sports injuries, owing to their ability to stimulate natural healing. Suturing has significantly transformed the wound closure process by accelerating it. However, wound care management is a complex process and surgical site infections are the most common medical infections observed among the large population. According to WHO, in low- and middle-income countries, 11% of patients who undergo surgery develop an infection during the process. To fight against surgical site infections, scientists have developed nanosilver-impregnated silk sutures. Nanosilver possesses antimicrobial properties, and its optical and structural characteristics make it an appealing candidate for biomedical applications. The increasing number of cases of surgical site infections is driving the need for sutures that have antimicrobial properties. In July 2022, Dolphin Sutures launched its antibacterial range of antibacterial sutures containing Triclosan coating, which is a known broad-spectrum antibacterial and antifungal agent. Therefore, increasing prevalence of surgical site infections are expected to create demand for antimicrobial surgical sutures and drive the growth of antimicrobial surgical sutures market.

South & Central America Antimicrobial Surgical Suture Market Country Insights

Based on country, the South & Central America antimicrobial surgical suture market comprises Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2023.

Brazil is the fifth largest and fifth most populated country globally. It is also known as the best medical tourism destination among the countries which offer medical tourism. The Joint Commission International has accredited 15 hospitals and medical centers in Brazil. These are concentrated in Rio De Janeiro and Sao Paulo. In addition, Brazilian plastic surgery is prevalent. Most hospitals and clinics specialize in orthopedics, cardiology, diagnostic medicine, dental, urology, neurology, and mastology. Moreover, travelers with limited budgets prefer Brazil for their medical treatments and other facilities due to the lower costs of surgical therapies compared to other regions. Therefore, owing to the rise in medical tourism for surgical treatments, the demand for antimicrobial surgical sutures is likely to increase during the forecast period.

The general population is covered by public health insurance. The Unified Healthcare System (SUS) is the primary provider of health services to the Brazilian population, and nearly 70% of the population is covered by healthcare services. Furthermore, the public system provides free medical diagnostics, treatment, and medication for some chronic diseases. These factors are boosting the demand for surgical treatments in the country, propelling the market growth.

South & Central America Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; TI Medical; and Unilene, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Product Code: BMIRE00031801

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Antimicrobial Surgical Suture Market - Key Market Dynamics

4.1 Market Drivers:
- 4.1.1 Surging Prevalence of Surgical Site Infections
- 4.1.2 Increasing Cases of Chronic Wounds and Surgeries
4.2 Market Restraints
- 4.2.1 Non-invasive Alternatives to Stitches
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
4.4 Future Trends
- 4.4.1 Smart Antimicrobial Sutures
4.5 Impact of Drivers and Restraints:

5. Antimicrobial Surgical Suture Market - South & Central America Market Analysis

5.1 South & Central America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
5.2 South & Central America Antimicrobial Surgical Suture Market Forecast Analysis

6. South & Central America Antimicrobial Surgical Suture Market Analysis - by Type

6.1 Triclosan Antimicrobial Suture
- 6.1.1 Overview
- 6.1.2 Triclosan Antimicrobial Suture: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Chlorhexidine Antimicrobial Suture
- 6.2.1 Overview
- 6.2.2 Chlorhexidine Antimicrobial Suture: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

7. South & Central America Antimicrobial Surgical Suture Market Analysis - by Raw Materials

7.1 Polyglactin 910 Antimicrobial Suture
- 7.1.1 Overview
- 7.1.2 Polyglactin 910 Antimicrobial Suture: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Poliglecaprone 25
- 7.2.1 Overview
- 7.2.2 Poliglecaprone 25: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Polyglycolic Acid
- 7.3.1 Overview
- 7.3.2 Polyglycolic Acid: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Antimicrobial Surgical Suture Market Analysis - by Application

8.1 Cardiovascular Surgery
- 8.1.1 Overview
- 8.1.2 Cardiovascular Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.2 General Surgery
- 8.2.1 Overview
- 8.2.2 General Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Ophthalmic Surgery
- 8.3.1 Overview
- 8.3.2 Ophthalmic Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Gynaecological Surgery
- 8.4.1 Overview
- 8.4.2 Gynaecological Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Orthopedic Surgery
- 8.5.1 Overview
- 8.5.2 Orthopedic Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Plastic Surgery
- 8.6.1 Overview
- 8.6.2 Plastic Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Veterinary Surgery
- 8.7.1 Overview
- 8.7.2 Veterinary Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.8 Dental Surgery
- 8.8.1 Overview
- 8.8.2 Dental Surgery: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. South & Central America Antimicrobial Surgical Suture Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. South & Central America Antimicrobial Surgical Suture Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Antimicrobial Surgical Suture Market Overview
- 10.1.2 South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 Brazil: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 Brazil: South & Central America Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.1.2 Brazil: South & Central America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.1.3 Brazil: South & Central America Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.1.4 Brazil: South & Central America Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.2 Argentina: South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Argentina: South & Central America Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.2.2 Argentina: South & Central America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.2.3 Argentina: South & Central America Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.2.4 Argentina: South & Central America Antimicrobial Surgical Suture Market Breakdown, by End User
  - 10.1.2.3 Rest of South & Central America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 Rest of South & Central America Antimicrobial Surgical Suture Market Breakdown, by Type
    - 10.1.2.3.2 Rest of South & Central America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
    - 10.1.2.3.3 Rest of South & Central America Antimicrobial Surgical Suture Market Breakdown, by Application
    - 10.1.2.3.4 Rest of South & Central America Antimicrobial Surgical Suture Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies
- 11.2.1 Overview
11.3 Company Market Share Analysis (%), 2023

12. Company Profiles

12.1 TI Medical
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Healthium Medtech Limited
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Meril Life Sciences Pvt Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Unilene
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Johnson & Johnson
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Futura Surgicare Pvt Ltd (Dolphin Sutures)
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Advanced MedTech Solutions Pvt. Ltd.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Internacional Farmaceutica SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms